| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.09 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |